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Abstract
Objective: We describe a new method for identifying and quantifying the magnitude
and rate of short-term weight faltering episodes, and assess how (a) these episodes
relate to broader growth outcomes, and (b) different data collection intervals influ-
ence the quantification of weight faltering.
Materials and methods: We apply this method to longitudinal growth data collected
every other day across the first year of life in Gambian infants (n = 124, males = 65,
females = 59). Weight faltering episodes are identified from velocity peaks and tro-
ughs. Rate of weight loss and regain, maximum weight loss, and duration of each epi-
sode were calculated. We systematically reduced our dataset to mimic various
potential measurement intervals, to assess how these intervals affect the ability to
derive information about short-term weight faltering episodes. We fit linear models
to test whether metrics associated with growth faltering were associated with
growth outcomes at 1 year, and generalized additive mixed models to determine
whether different collection intervals influence episode identification and metrics.
Results: Three hundred weight faltering episodes from 119 individuals were identi-
fied. The number and magnitude of episodes negatively impacted growth outcomes
at 1 year. As data collection interval increases, weight faltering episodes are missed
and the duration of episodes is overestimated, resulting in the rate of weight loss and
regain being underestimated.
Conclusions: This method identifies and quantifies short-term weight faltering epi-
sodes, that are in turn negatively associated with growth outcomes. This approach
offers a tool for investigators interested in understanding how short-term weight fal-
tering relates to longer-term outcomes.
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1 | INTRODUCTION
Determining whether an individual's growth is due to natural/normal
variation or is indicative of adverse conditions, and pinpointing when
growth perturbations begin (Victora et al., 2010), are areas of contin-
ued research and debate. It is standard and near-universal practice
among health care workers to monitor growth during infancy and
childhood to pick up on potential disturbances to a child's growth tra-
jectory as potential indicators of challenges to health (de Onis &
Branca, 2016). Growth standards, such as World Health Organization
(WHO)-guided thresholds for wasting and stunting (i.e., below-2SDs
from the WHO Child Growth Standards median for weight-for-height
and height-for-age z-scores, respectively [WHO Multicentre Growth
Reference Study Group, 2006]) are internationally accepted (de Onis
et al., 2013; WHO, 2008). While metrics such as wasting and stunting
may indicate when an individual is not growing normally relative to a
reference population, they dichotomize the inherently continuous
process of growth faltering (de Onis & Branca, 2016) and have only
been able to resolve the initiation of the state of growth faltering as
happening in utero or the first 1000 days of life (Christian et al., 2013;
de Onis et al., 2013; Dewey & Huffman, 2009). Thus, the appropriate
method for determining when a growth perturbation is initiated and
subsequently resolved, and what combination of factors caused the
perturbation, remains unresolved.
Several approaches can identify growth faltering or loss of growth
potential, but each have drawbacks that preclude the study of the
proximate mechanisms of acute faltering events. First, WHO Growth
Reference (WHO Multicentre Growth Reference Study Group, 2006)
cutoffs indicate small size or stature relative to the reference, with a
height-for-age (HAZ), weight-for-age (WAZ), and weight-for-height
(WFH) < −2 SD as the standard cutoff, as noted above (Alderman &
Headey, 2018). Although these cutoffs are often used to indicate fal-
tering in a given anthropometric dimension at a given age, they are
limited in utility as an individual who falls at or below these cutoffs
may have started out small, meaning they are tracking their appropri-
ate trajectory. This static approach only measures attained growth at
a given time point, and encompasses neither change over time or min-
imizes variation in growth trajectories among individuals (Eveleth &
Tanner, 1976; Lampl et al., 2015). Second, raw growth cutoffs use a
predefined gain in weight or height below which is indicative of falter-
ing (Martorell & Shekar, 1994). However, this approach has no inde-
pendent, robust basis for cutoff selection; individual researchers must
arbitrarily decide how little gain or how much loss is indicative of fal-
tering. Third, centile crossing indicates an individual deviating from
their growth trajectory; here, faltering is defined as when an individual
crosses down more than two major (i.e., 5th, 10th, 25th, 50th, 75th,
90th, 95th) centiles (Wright, 2000). Although this method is more
dynamic in its ability to look at change over time, counting centiles is
both noncontinuous and imprecise due to the uneven spacing of the
centiles. Fourth, z-score deviations and conditional anthropometry are
usually applied to height (Argyle, 2003), with a negative change in
z-score indicative of faltering (Cole, 1993; Healy, 1974; Shrimpton
et al., 2001; Victora et al., 2010; Waterlow et al., 1977). Although the
generation of conditional z-scores requires normally distributed
anthropometric data (Waterlow et al., 1977) or transformative proce-
dures which presuppose otherwise undefined “normal” growth
(Cole, 1993), they have been applied to shorter collection intervals
(Cole, 1995; Wright et al., 2006).
Though the latter two methods of assessing growth faltering per-
mit detection of an individual deviating from their growth trajectory,
there exists a gap in our ability to quantify those deviations in a stan-
dardized and precise way. A new approach is needed to link the devia-
tion from one's trajectory with the proximate mechanisms that caused
the individual to falter, then further link this to explicit adverse condi-
tions (particularly during the first 1000 days of life) with later growth
and health outcomes. Growth faltering has two facets: (a) the state of
faltering, related to potential growth comprised of genetic potential
plus factors that constrain how much one can growth at a given time,
resulting in a given outcome for age (e.g., a specific z-score); and
(b) faltering episodes, or short-term growth deficits resulting from var-
ious factors and which cumulatively result in the state of growth fal-
tering (e.g., an individual ending up smaller than they “should” have
given their initial trajectory). Growth faltering both as a process and as
an outcome has been linked to a myriad potential negative impacts
increased morbidity and disease risk (Black et al., 2008;
Hoffman, 2014; Olofin et al., 2013), reduced stature (Stein
et al., 2010), and increased risk of obesity from subsequent catch-up
growth (Ong et al., 2000; Ong et al., 2015). To better understand how
the process of growth faltering leads to different growth and health
outcomes, we need to be able to characterize the specific aspects of
faltering, such as timing, magnitude, and rate.
Here, we propose a novel method for identifying weight growth
faltering episodes and quantifying their magnitude and rate, and dem-
onstrate its utility and application using longitudinal weight data from
a cohort of Gambian infants, designed to explore growth in the first
1000 days in fine detail (Moore et al., 2020). Our primary objective is
to apply this method to identify, for each individual infant growth tra-
jectory across the first year of life, weight-faltering episodes that are
mathematically defined based on changes in growth velocity, and to
determine what effect the magnitude and rate of these episodes have
on growth outcomes at 1 year of age. Tracking growth velocity, spe-
cifically changes in growth velocity, has proven to be a sensitive
method of monitoring changes in growth due to pathology
(Tanner, 1990). To maximize the utility of this method for future study
design and implementation, our second objective is to explore the
relationship between measurement collection interval and faltering
metrics identified, and specifically to assess the extent of information
lost when measurements are collected over broader intervals.
2 | MATERIALS AND METHODS
2.1 | Study subjects and site
Data for this study were obtained from the Hormonal and Epige-
netic Regulators of Growth (HERO-G) cohort, recruited from a rural
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subsistence farming population in the West Kiang region of The
Gambia. The full study protocol has been published elsewhere
(Moore et al., 2020). Infants from the cohort were visited by a
trained field assistant every alternate day from 9 to 365 days of
post-natal life. At each visit, a panel of anthropometrics were col-
lected. The current analysis focuses on weight, which was recorded
on handheld tablets in triplicate to the nearest 10 g using a Seca
336 digital weighing scale. Some models also include outcomes cal-
culated based on infant length (HAZ, WHZ). Infant crown-heel
length was also recorded in triplicate to the nearest 0.1 cm, using a
Seca 417 length board. Field assistants received comprehensive
training in anthropometric measurement at the start of the study;
regular standardization exercises were performed to measure inter-
observer variation (Moore et al., 2020). Data capture software entry
was designed such that each anthropometric measurement was
taken once, after which the screen would refresh and each measure-
ment would be taken again, following collection of the full panel of
anthropometric measures, to help reduce intra-observer bias. Infants
were weighed naked where possible; in some cases, light twine
bracelets or necklaces, worn at all times throughout the study,
remained on an infant even after clothing was removed. Mothers
refrained from breastfeeding during measurement and were asked
to not feed their infant prior to measurement. A total of 124 infants
(male = 65 with 142–177 measurements each, female = 59 with
140–175 measurements each) were included in this study from the
original cohort (N = 238) based on these individuals having near-
complete weight growth curves; specifically, HERO-G infants were
included in this analysis if they had fewer than five missing consecu-
tive weight measurements across the first year of life. The average
of all three replicate weight measures was used when the coefficient
of variation (CV) of the triplicates was below 5% (99.5% of observa-
tions). If CV was greater than 5%, and one triplicate was at least one
whole number above or below the remaining two triplicates, then
that triplicate was dropped and the average of the remaining two
was used instead. Intraobserver technical error of measurement
(TEM) was calculated for each anthropometrist (N = 21) and their
collected data using one set of triplicate measurements from each
study subject from each month (12 monthly triplicate measurements






equals each replicate deviation, and N equals the number of subjects
that fieldworker measured (Ulijaszek & Kerr, 1999). See “Statistics”
section below for information regarding application of intra-
observer TEM.
The HERO-G study was approved by the joint Gambia Govern-
ment / MRC Unit The Gambia Ethics Committee (Project number
SCC1313v3), and the University of Colorado Boulder Institutional
Review Board (protocol number 13–0441). Prior to the start of the
study, community approval was obtained from each participating vil-
lage. Participating women were given the option of either reading the
consent form on their own or having it read to them by a trained field
assistant in their language. After given an opportunity to consider
their involvement and talk to family members, written, informed con-
sent was obtained from each participating mother.
2.2 | Faltering episode identification and
quantification: Method description
The following approach was applied to individual weight growth cur-
ves, which identified faltering episodes, deconstructed each into com-
ponent stages, and quantified their magnitude. For each individual, a
linear interpolation was performed to impute missing data, given the
limited amount of missing data. A 25-knot cubic spline was then fitted
to the resulting weight curve to smooth out minor day-to-day fluctua-
tions, potentially due to the intake and excretion of breas tmilk, water,
and non-breas tmilk food, while still retaining the overall shape of the
curve (Figure 1). This knot was chosen by fitting different knots
(range: 5–50) in iterative fashion to individual growth trajectories, and
visually identifying which knot best followed the shape of the trajec-
tory without overfitting day-to-day shifts. The first derivative was
then calculated across the splined weight curve, and peaks and tro-
ughs identified where the first derivative was equal to zero using the
find_peaks function (Aphalo, 2018; see R code in Supplementary
Materials). Stages of individual faltering episodes (Figure 2:1–4) were
defined as:
1. Initiation: when the first derivative transitioned from positive to
negative (i.e., a peak).
2. Dip: the subsequent period of weight loss.
3. Depth maximum: when the first derivative transitioned from nega-
tive to positive (i.e., a trough).
4. Rebound: the period of weight gain following depth maximum,
continuing until the individual re-attains the weight at which the
episode was initiated. The last weight measurement equal to or
less than the weight at Initiation of the episode is the final mea-
surement in the rebound stage, at which point the episode termi-
nates. If the measurement immediately following depth maximum
F IGURE 1 A single individual's raw weight curve plotted over the
first year of life. Red line indicating the chosen 25-knot cubic spline.
Spline curve is sensitive to larger fluctuations in weight while
smoothing out day-to-day natural variation in weight measurements
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is higher (i.e., in weight) than the measurement at Initiation, the
episode terminates at the depth maximum.
Using this method, a range of metrics can be calculated from each
identified faltering episode (Figure 2a–d). Individual episodes and their
stages can be quantified in terms of their duration (length of time
from Initiation to the end of rebound), rate (i.e., of loss and regain),
and depth (maximum amount of weight lost during the episode). Num-
ber of faltering events initiated, the average depth of the episodes,
and the proportion of time spent within faltering episodes
(encompassing initiation, dip, depth maximum, and rebound) across
the first year were calculated and compared between individuals. Rate
of weight loss during the dip period for each faltering episode was cal-
culated from Initiation to depth maximum, and the rate of weight gain
during the rebound period was calculated from depth maximum to the
last observation equal to or less than the Initiation of the given falter-
ing episode. Each rate is expressed as grams/day, for comparison
between the different collection intervals. Neither rate was calculated
for a given faltering episode if (a) the rebound stage did not start
before the end of data collection for the particular subject (day 365),
or (b) if the weight measurement following the faltering episode's
depth maximum was higher than the weight at Initiation. In this sec-
ond case, the duration of the rebound period cannot be calculated,
either. This is not an issue for the raw data used in this study but
becomes relevant when looking at data mimicking longer collection
intervals (see below). As an example, the individual shown in Figure 3
shows a faltering episode Initiation ~250 days. At anthropometric
collection intervals up to and including once weekly, the true rebound
of this particular faltering episode is successfully identified. When
measured twice monthly or monthly, however, the rebound of this
episode is missed.
2.3 | Statistics
To evaluate measurement error in a longitudinal and study-specific
way, mean intra-observer TEM across fieldworkers in this study





, with D being the deviation two
given replicates and N being the total number of subjects that
fieldworker measured. This was then used to calculate the amount of
weight loss (>14 g) within a given episode in excess of which we could
be 95% confident was not due to measurement error alone, using the
equation 2*
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TEMð Þ2 + TEMð Þ2
q
(Ulijaszek & Kerr, 1999). This provides
a diagnostic tool to filter out episodes by estimating the proportion of
difference between two measures, in this case the Initiation and depth
maximum of a given episode, beyond which might be attributed to
measurement error alone. Episodes with a depth in excess of 14 g
were retained for analysis. Given the frequency of data collection, a
potential issue arises regarding intra-daily micro-changes in weight,
such as those due to urination, where identified episodes may be due
to non-tissue changes in weight. We reran all analyses excluding epi-
sodes with a depth in excess of 74 g, obtained by addition of the initial
14 g threshold plus 60 g representing the upper range of weight of a
full (60ml) bladder of a 9-month old infant (Guerra et al., 2014). We
report both sets of results, and refer to results based on the 14 g
threshold in subsequent text unless otherwise stated.
We fit linear models to determine if derived faltering metrics pre-
dict broad changes to attained growth trajectory across the first year.
Weight and height were converted into WAZ, HAZ, and WFH
according to WHO references (WHO Multicentre Growth Reference
Study Group, 2006) at our first (day 9 of postnatal life) and last
(12 months) measurements used in the current analysis. Twelve
month z-scores were set as outcomes and faltering metrics (number
of falters, average falter depth, average rate of dip and rebound and
their interaction, sex, and baseline z-score) as predictors. Model fit
was assessed for normality and heteroscedasticity of residuals, and
multicollinearity. Terms were dropped in sequential fashion if any vari-
ance inflation factor (VIF) exceeded five (Sheather, 2009) and AIC was
reduced by at least two, until all terms fell below five. To determine
whether episodic effects are more characterized by acute or chronic
weight loss, we fit a generalized additive mixed model (GAMM) with
depth as the outcome and dip and rebound durations as smoothed
predictors using the MGCV package in R (R Development Core
Team, 2015; Wood, 2006, 2019).
To test whether increasing the collection interval length, and thus
decreasing anthropometric data resolution, alters the identification
and quantification of growth faltering using this method, we subset
our data to mimic anthropometry collected at intervals of 4, 8, 16, and
32 days. These are serial doublings of our original collection interval,
roughly approximate to measurements collected twice weekly,
F IGURE 2 Demonstration of method application to a single
individual. Smoothed weight is plotted over the first year of life, and
each faltering episode identified. Letters indicate each faltering
episode (four total falter episodes). Numbers and colors indicate
faltering episode stages: 1—Initiation (+): transition from positive to
negative growth rate, at which the first derivative is equal to zero;
2—dip (5): loss of weight following episode initiation; 3—depth
maximum (X): transition from negative to positive growth rate, at
which the first derivative is equal to zero; 4—rebound (□): gain of
weight following maximum depth until weight at time of episode
Initiation is re-attained
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weekly, twice monthly, and monthly. We then applied the same falter-
ing method protocol to each collection interval, quantifying the num-
ber of faltering episodes and their metrics, and averaging each metric
across the collection period for each study subject. GAMMs were
fitted with the eight individual-level faltering metrics (count, depth,
proportion, episode duration, dip duration, rebound duration, dip rate,
and rebound rate) as outcomes, with sex and collection interval fit as
linear and smooth terms, respectively, and subject ID as a random
effect. Episode count was fit with a Poisson distribution while the
other seven metrics were fit with Gaussian distributions. All descrip-
tive statistics are presented as means ± standard deviation. Identifica-
tion and quantification of faltering episodes, and all subsequent
statistical analyses, were performed in Rv3.6.1. (R Development Core
Team, 2015).
3 | RESULTS
We identified 300 weight faltering episodes from 119 individuals
(2.52 ± 1.14, range: 1–6, Table 1). Five individuals had no detected
weight faltering episodes; each of these individuals was born in the
dry season, and four were conceived in the wet season. On average,
infants spent ~9% of their first year of life within weight faltering
episodes, lost 170 g per episode at a rate of 8.9 g/day, and regained
that lost weight at a rate of 9.9 g/day. These episodes lasted an aver-
age of 1 month, with considerable variation in total episode duration
(range: 16–170 days). Further, the dip and rebound stages both
exhibited wide variation in duration (dip:10–48 days; rebound:5–148-
days), despite having similar averages (dip:18.32 days;
rebound:14.59 days). When using the stricter 74 g threshold for inclu-
sion, our results show that infants spent ~10% of their first year of life
within weight faltering episodes, lost 254 g per episode at a rate of
12.7 g/day, and regained that lost weight at a rate of 13.3 g/day,
remaining generally consistent with the results using the 14 g thresh-
old for inclusion, with higher values reflecting the higher weight
cutoff.
Attained growth models (WAZ, HAZ, WFH at 12 months as the
outcome) each followed a similar pattern in relation to faltering epi-
sode metrics (Table 2). After adjustment for baseline z-score, the
interaction of dip and rebound rates, and subsequently dip rate itself,
were removed from all models due to nonsignificance and high VIF,
respectively. The remaining faltering metrics (count, depth, and
rebound rate) explained the most variance in WAZ (R2ajd = 0.27),
followed by HAZ (R2ajd = 0.18) and WFH (R
2
ajd = 0.08). WAZ was
inversely associated with number of faltering episodes (β = −0.14).
Greater depth (i.e., more weight lost) was associated with lower WAZ
F IGURE 3 Demonstration of method application to different data collection intervals. The observed data are plotted in the upper left panel.
Remaining panels indicate the smoothed spline curve at the 2-, 4-, 8-, 16-, and 32-day interval, respectively
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(β = −1.77) and HAZ (β = −2.31), but not WFH. Increased rebound
rate was associated with higher WAZ (β = 52.81), HAZ (β = 61.28),
and WFH (β = 48.51). Sex did not emerge as a significant predictor in
any model. dip duration, but not rebound duration, was a significant
predictor of depth (R2adj = 0.43, F(4.37) = 25.47, p < 0.0001), with
increasing dip duration corresponding with greater weight lost.
Models fit with data from the 74 g inclusion threshold were consis-
tent with those fit with the lower 14 g threshold, except that average
depth had a weaker effect, R2adj increased, and AIC decreased in all
three models (Table S1).
Simulated collection interval significantly predicted all derived fal-
tering metrics irrespective of sex (Table 1). As simulated collection
TABLE 1 Faltering episode metrics calculated using each simulated interval
Interval (days)
2 4 8 16 32
Inclusion
threshold (g)
14 g 74 g 14 g 74 g 14 g 74 g 14 g 74 g 14 g 74 g
Subjects N 119 (96%) 100 (81%) 118 (95%) 100 (81%) 115 (93%) 95 (77%) 105 (85%) 84 (68%) 58 (47%) 42 (34%)
Count Mean 2.52 1.83 2.45 1.75 2.30 1.59 1.86 1.45 1.17 1.12
SD 1.14 0.93 1.15 0.93 1.08 0.84 0.84 0.70 0.38 0.33
Min 1.00 1 1.00 1 1.00 1 1.00 1 1.00 1
Max 6.00 5 6.00 5 5.00 5 5.00 4 2.00 2
Depth Mean 169.90 253.83 166.12 247.09 160.61 250.04 175.78 252.23 193.45 256.07
(g) SD 146.09 184.84 142.19 185.47 141.23 184.82 154.93 180.86 184.20 189.09
Min 20.00 80.00 20.00 80.00 20.00 80.00 20.00 80.00 20.00 80.00
Max 1115.00 1115.00 1115.00 1115.00 1100.00 1100.00 980.00 980.00 850.00 850.00
Proportion Mean 0.09 0.10 0.11 0.12 0.16 0.15 0.22 0.19 0.22 0.19
(% first year) SD 0.05 0.04 0.07 0.06 0.12 0.09 0.13 0.12 0.08 0.04
Min 0.04 0.05 0.03 0.04 0.02 0.02 0.04 0.04 0.16 0.16
Max 0.47 0.26 0.37 0.35 0.57 0.46 0.53 0.48 0.41 0.25
Dip duration Mean 18.32 21.81 18.57 22.2 19.23 22.88 22.43 25.81 35.95 37.5
17.29 SD 6.12 6.81 6.92 7.54 6.83 7.96 8.36 12.01 15.37 17.29
Min 10.00 11.00 8.00 12.00 8.00 8.00 16.00 16.00 30.00 30.00
Max 48.00 48.00 52.00 52.00 48.00 48.00 48.00 80.00 90.00 90.00
Rebound
duration
Mean 14.59 16.22 21.73 22.01 41.11 30.51 58.72 46.04 45.00 33.33
(days) SD 16.82 10.25 25.41 18.98 43.20 33.51 50.06 44.15 30.00 10.00
Min 4.00 4.00 4.00 4.00 8.00 8.00 16.00 16.00 30.00 16.00
Max 148.00 70.00 128.00 100.00 192.00 160.00 176.00 160.00 120.00 60.00
Episode duration Mean 32.90 38.08 40.00 44.82 60.44 53.47 80.41 70.67 80.00 70.00
(days) SD 19.34 13.99 26.13 21.75 42.05 33.32 47.21 42.08 29.54 15.00
Min 16.00 18.00 12.00 16.00 16.00 16.00 16.00 16.00 60.00 60.00
Max 170.00 96.00 136.00 128.00 208.00 168.00 192.00 176.00 150.00 90.00
Dip rate Mean −8.93 −12.72 −8.03 −10.98 −7.68 −11.05 −7.61 −10.36 −5.69 −7.52
(g/day) SD 10.50 16.41 4.97 6.32 5.14 6.35 5.45 6.01 5.57 5.85
Min −1.25 −3.54 −1.00 −3.86 −1.25 −3.33 −1.25 −2.5 −0.67 −1.67
Max −108.77 −162.08 −32.66 −39.38 −36.39 −36.39 −31.67 −31.67 −28.33 −28.33
Rebound rate Mean 9.94 13.03 8.01 11.28 7.47 9.47 6.96 8.57 4.33 5.70
(g/day) SD 6.14 8.29 6.00 7.53 6.16 7.62 7.82 8.89 4.10 3.82
Min 1.67 0 0.48 0 0.11 0 0.25 0 0.33 1.00
Max 44.55 44.55 50.56 50.56 47.66 47.66 40.63 40.62 12.00 12.00
Note: Values represent subjects (N) with identifiable faltering episodes after adjustment for TEM (depth > 14 g) or TEM and non-tissue weight change
(depth > 74 g) at each time interval. Included is the percentage of individuals with identified episodes out of all included subjects (N = 124). Mean, SD,
minimum, and maximum are calculated for each metric by interval.
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interval increased from 2 to 32 days, the total number of identifiable
weight faltering episodes dropped, as did the total number of subjects
with at least one identifiable episode (Table 1). Average, as well as
minimum and maximum, number of identified episodes dropped sig-
nificantly as collection interval increased (R2adj = 0.15, F(1) = 46.84,
p < 0.0001). Episode depth decreased from 2- to 8-day intervals, then
increased up to the 32-day interval, indicating that longer collection
intervals can overestimate depth, though minimal variation in depth
overall was explained by interval (R2adj = 0.012, F(1) = 4.86, p = 0.028).
Episode depth remained roughly consistent in value across all collec-
tion intervals when using the 74 g inclusion criterion (Table 1). Pro-
portion of time spent in episodes increased up to the 16-day interval
then leveled off (R2adj = 0.21, F(2.46) = 42.05, p < 0.0001). Average
proportions remained relatively low across intervals (average:
9%–22%), though some individuals spent a considerable proportion of
their first year within faltering episodes (maximum: 37%–57%).
These proportion changes are reflected in the duration and rate
metrics. Dip and rebound duration both increased with greater collec-
tion interval from ~2 weeks to over 1 month (dip: R2adj = 0.286, inter-
val: F(2.55) = 117, p < 0.0001; rebound: R
2
adj = 0.176, interval:
F(2.56) = 32.02, p < 0.0001). Episode duration, being a by-product of
these durations, followed the same pattern (R2adj = 0.214,
F(2.46) = 42.24, p < 0.0001). Dip and rebound rate both trended
towards zero as interval increased, indicating a drift towards underes-
timation with increasing collection interval. Collection interval signifi-
cantly influenced both rates (dip rate, interval: F(1) = 23.84, p < 0.001;
rebound rate, interval: F(1.86) = 21.15, p < 0.0001), though they
explained little variance in outcome (dip rate: R2adj = 0.02; rebound
rate: R2adj = 0.043).
4 | DISCUSSION
We present a new method and framework for identifying and quanti-
fying short-term weight faltering episodes. This approach, and the
ability to quantify aspects of individual episodes, can provide the con-
text to link acute conditions to the broader state of faltering from an
individual's potential growth trajectory. Faltering metrics significantly
predicted relative attained growth at 1 year after accounting for size
at 1 week, suggesting that they are relevant for predicting infant
growth outcomes. As these are weight faltering episodes, it is not sur-
prising that they would have the strongest effect on and explain the
most variance in WAZ. Their relationship to HAZ is noteworthy,
though they explain only ~20% of variance in HAZ at 1-year (Table 2).
While the number of episodes did not impact linear growth, average
depth had a dramatic effect: for every 1 kg of average depth, there
was a − 2.31 drop in HAZ at 1 year. That the mean depth of episodes
was ~170 g, and ~ 95% of episodes had a depth < 814 g, suggests
such deep episodes are uncommon (Table 1). Taken together with the
positive association between dip duration and depth, this suggests
that weight faltering negatively effects linear growth through path-
ways that can include frequent, low magnitude episodes and/or
TABLE 2 Outputs for models of z score outcome against faltering metrics
Model Full model statistics Model terms β (95% CI) t-stat, p-value
1 WAZendline ~ sex +
WAZbaseline + # of falters +
depth + rebound rate




Intercept −0.59 (−1.05, −0.12) t = −2.5, p = 0.014
Sex −0.25 (−0.55, 0.05) t = −1.67, p = 0.1
WAZ at birth 0.47 (0.28, 0.5) t = 5.03, p < 0.0001
# of falters −0.14 (−0.27, −0.01) t = −2.12, p = 0.037
Average Depth −1.77 (−3.33, −0.20) t = −2.23, p = 0.028
Average rebound rate 52.81 (15.88, 89.75) t = 2.84, p < 0.01
2 HAZendline ~ Sex +
HAZbaseline + # of falters +
depth + rebound rate




Intercept −0.98 (−1.44, −0.52) t = −4.24, p < 0.0001
Sex −0.04 (−0.36, 0.28) t = −0.25, p = 0.80
HAZ at birth 0.24 (0.12, 0.36) t = 3.93, p < 0.001
# of falters −0.009 (−0.15, 0.13) t = −0.13, p = 0.90
Average depth (kg) −2.31 (−3.4, −0.64) t = 02.75, p < 0.01
Average rebound rate 61.28 (22.43, 100.13) t = 3.13, p < 0.01
3 WFHendline ~ Sex +
WFHbaseline + # of falters +
depth + rebound rate




Intercept −0.59 (−1.14, −0.04) t = −2.14, p = 0.035
Sex −0.31 (−0.68, 0.06) t = −1.65, p = 0.1
WFH at Birth 0.11 (0.01, 0.21) t = 2.08, p = 0.04
# of falters −0.15 (−0.31, 0.01) t = −1.82, p = 0.07
Average depth (kg) −1.39 (−3.31, 0.53) t = −1.43, p = 0.16
Average rebound rate 48.51 (2.68, 94.34) t = 2.1, p = 0.038
Note: Depth and rebound rate units in kilograms. Current models resulted from initial removal of nonsignificant dip rate x rebound rate interaction term,
and removal of dip rate due to high collinearity. Female is the baseline sex. Each model checked for normality of residuals using a Shapiro–Wilk test, and
for homoscedasticity of residuals using a score test for nonconstant error variance. Multicollinearity was assessed using variance inflation factor.
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infrequent, high magnitude episodes. Further, the rate of rebound is
significant in all models, following either inclusion criterion, except for
WFH at the stricter threshold (Table S1), indicating this period as a
critical window for the determination of growth outcomes. This find-
ing builds on prior work in this population that demonstrated repeated
rounds of wasting increases the risk of stunting (Schoenbuchner
et al., 2019). The positive association between rebound rate and each
growth outcome suggests that understanding the dynamics of weight
growth faltering are critical for understanding the mechanisms under-
lying these outcomes, and their continued prevalence across much of
the world (Shrimpton et al., 2001; Victora et al., 2010).
Simulated collection interval significantly influenced all faltering
metrics in infants. In all cases, increasing the interval across which
anthropometrics were collected led to loss of information, especially
at the monthly interval. As collection intervals increase, faltering epi-
sodes were missed, the amount of actual weight lost deviated from
that recorded in the 2-day interval, and dip and rebound rates were
underestimated, making some episodes seem less severe than they
actually were. Though collecting more frequent anthropometric data
can be logistically challenging, twice monthly and monthly intervals in
this population appear to be insufficient to reveal the episodic nature
of short-term weight loss and regain (Figure 3), as they underestimate
the severity (i.e., rate and depth) of the rate at which it proceeds, and
increasingly miss episodes to the point that many individuals appear
to experience none at all. Because both rate metrics are prone to
underestimation, the shortest possible collection interval should be
used if either are to be captured and their contribution assessed. The
relationship between lower magnitude weight faltering episodes and
longer-term growth outcomes is unclear, and the cost in time and
resources of more frequent measurement, versus the risk of missing
smaller episodes should be carefully considered within the context of
overall monitoring goals.
Although we applied this method to a data set retrospectively for
the purposes of method development, we propose that it can be
implemented in real-time in field research and clinical settings to iden-
tify the initiation of faltering episodes, providing critical information
regarding a weight faltering episode's magnitude, and allowing for the
timely deployment of (a) targeted intervention measures to rectify the
faltering episode, and/or (b) additional strategic growth data collection
to follow the response to intervention in real time. For example, a
researcher could monitor the individual illustrated in Figure 3 at all
but the monthly interval and still identify weight faltering episodes
using the approach presented here. When an Initiation is noted (such
as the one shortly after 100 days), that individual would be flagged
and the faltering episode followed up. Depending on the aims of the
study that employs the method, follow up could call for evaluation by
a community health worker and treatment if needed, a shift to a
higher-resolution collection interval, initiation of nutritional interven-
tion, clinical evaluation, and so on. Future studies should be sure to
consider potential non-tissue changes in weight; a full bladder, recent
feeding, or the presence of undergarments could inflate observed
weight without affecting actual tissue weight, potentially resulting in
false identification of faltering episodes. Overall, this method offers a
standardized framework for exploring and responding to the dynamics
of growth faltering across settings, and allowing a more nuanced
understanding of the causes and consequences of short-term weight
loss/regain in infants and young children.
We suggest that this method complement centile crossing
(Wright, 2000) and z-score deviations (Argyle, 2003; Cole, 1995)
approaches for analyzing growth faltering. Stunting and growth falter-
ing remain global problems despite fervent and focused efforts to
combat them (Shrimpton et al., 2001; Victora et al., 2010), and new
approaches to the identification and analysis of faltering are needed.
If the global issue of stunting is to be addressed, its dynamic causes
must be identified and explored. From a mechanistic perspective, it is
clear that repeated rounds of growth faltering (e.g., resulting from high
morbidity, undernutrition, repeated seasonal pressures, or other
adverse conditions) could potentially (a) deplete resources available to
support growth (Stearns, 1989), and (b) signal a “high risk” environ-
ment to the developing individual, potentially impacting growth pat-
terns and health in both the short- and long-term (Bernstein
et al., 2020; Gluckman et al., 2005). Close analysis of the dynamics of
faltering episodes as presented here can help tease apart the causes
and consequences of faltering, shed light on how those episodes con-
tribute to the broader state of faltering from a “potential” trajectory
identified by prior methods, and may provide valuable insight regard-
ing the efficacy of interventions designed to improve growth and
growth outcomes.
There are three main limitations to this study. First, the method
cannot be applied to height measurements. This method assumes that
cessation of weight growth, or weight loss, during this time period is
abnormal, and thus indicative of deviation from a healthy growth tra-
jectory. Height does not necessarily follow this same pattern. Two
models of height growth, saltation, and stasis (Lampl et al., 1992) and
mini-growth spurts (Hermanussen, 1998; Hermanussen et al., 1998)
both incorporate lack of growth (i.e., stasis) in height within the defini-
tion of normal growth, suggesting apparent reductions in height gain
are normal and thus precluding the application of the method
described here to height. Second, while we reran our analyses with a
higher exclusion threshold based on bladder fullness and found con-
sistent results with the lower threshold, the possibility remains that a
small number of the weight faltering episodes we identified could
have been due to additional non-tissue weight differences that we did
not account for. Third, this study focuses only on outcomes at the end
of the first year of life. We therefore cannot yet fully link rebound to
catch-up growth across different stages of growth, given the range of
potential catch-up strategies. Catch-up growth can occur by increas-
ing growth rate above normal or extending the duration of growth
(Tanner, 1981); potentially, the latter could involve individuals catch-
ing up through adolescence (Allal et al., 2004). As such, rebound as we
have defined it here may not encompass catch-up growth that
involves an extension of the overall growth period, and should not be
considered to imply catch-up of growth potential. Thus, while
rebound (as used here) may encompass certain types of catch-up
growth, we recommend pairing this method with an approach which
tackles growth potential, such as z-score deviations.
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In summary, this study presents a novel method for identifying
and quantifying weight growth faltering, and tests the impact of dif-
ferent collection intervals on the refinement of weight faltering met-
rics. Incorporating this method into future study designs will require
tailoring data collection intervals to specific research questions, given
the changes to timing and duration components of episode metrics
that are associated with longer collection intervals. We hope that
future applications of this method will allow greater insights into what
causes weight growth faltering, how the body responds to challenges
in the context of various intrinsic and extrinsic factors, and what the
long-term consequences for individual growth and health outcomes
might be.
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